Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 27c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.21), $0.27 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $0 versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Needham
• Endava CFO placed on leave amid accounting probe
• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar